Rosseneu M - Search Results

1

Structure and function of lecithin cholesterol acyl transferase: new insights from structural predictions and animal models.

Peelman F, Vandekerckhove J, Rosseneu M. Peelman F, et al. Among authors: rosseneu m. Curr Opin Lipidol. 2000 Apr;11(2):155-60. doi: 10.1097/00041433-200004000-00008. Curr Opin Lipidol. 2000. PMID: 10787177 Review.

2

Structural and functional properties of the 154-171 wild-type and variant peptides of human lecithin-cholesterol acyltransferase.

Peelman F, Goethals M, Vanloo B, Labeur C, Brasseur R, Vandekerckhove J, Rosseneu M. Peelman F, et al. Among authors: rosseneu m. Eur J Biochem. 1997 Nov 1;249(3):708-15. doi: 10.1111/j.1432-1033.1997.t01-2-00708.x. Eur J Biochem. 1997. PMID: 9395317 Free article.

3

A proposed architecture for lecithin cholesterol acyl transferase (LCAT): identification of the catalytic triad and molecular modeling.

Peelman F, Vinaimont N, Verhee A, Vanloo B, Verschelde JL, Labeur C, Seguret-Mace S, Duverger N, Hutchinson G, Vandekerckhove J, Tavernier J, Rosseneu M. Peelman F, et al. Among authors: rosseneu m. Protein Sci. 1998 Mar;7(3):587-99. doi: 10.1002/pro.5560070307. Protein Sci. 1998. PMID: 9541390 Free PMC article.

4

Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity.

Peelman F, Verschelde JL, Vanloo B, Ampe C, Labeur C, Tavernier J, Vandekerckhove J, Rosseneu M. Peelman F, et al. Among authors: rosseneu m. J Lipid Res. 1999 Jan;40(1):59-69. J Lipid Res. 1999. PMID: 9869650 Free article.

5

Characterization of functional residues in the interfacial recognition domain of lecithin cholesterol acyltransferase (LCAT).

Peelman F, Vanloo B, Perez-Mendez O, Decout A, Verschelde JL, Labeur C, Vinaimont N, Verhee A, Duverger N, Brasseur R, Vandekerckhove J, Tavernier J, Rosseneu M. Peelman F, et al. Among authors: rosseneu m. Protein Eng. 1999 Jan;12(1):71-8. doi: 10.1093/protein/12.1.71. Protein Eng. 1999. PMID: 10065713

6

Relationship between structure and biochemical phenotype of lecithin:cholesterol acyltransferase (LCAT) mutants causing fish-eye disease.

Vanloo B, Peelman F, Deschuymere K, Taveirne J, Verhee A, Gouyette C, Labeur C, Vandekerckhove J, Tavernier J, Rosseneu M. Vanloo B, et al. Among authors: rosseneu m. J Lipid Res. 2000 May;41(5):752-61. J Lipid Res. 2000. PMID: 10787436 Free article.

7

Headgroup specificity of lecithin cholesterol acyltransferase for monomeric and vesicular phospholipids.

Christiaens B, Vanloo B, Gouyette C, Van Vynckt I, Caster H, Taveirne J, Verhee A, Labeur C, Peelman F, Vandekerckhove J, Tavernier J, Rosseneu M. Christiaens B, et al. Among authors: rosseneu m. Biochim Biophys Acta. 2000 Jul 19;1486(2-3):321-7. doi: 10.1016/s1388-1981(00)00075-5. Biochim Biophys Acta. 2000. PMID: 10903483

8

Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:cholesterol acyltransferase.

Roosbeek S, Vanloo B, Duverger N, Caster H, Breyne J, De Beun I, Patel H, Vandekerckhove J, Shoulders C, Rosseneu M, Peelman F. Roosbeek S, et al. Among authors: rosseneu m. J Lipid Res. 2001 Jan;42(1):31-40. J Lipid Res. 2001. PMID: 11160363 Free article.

The markedly decreased activities of mutants R149, R153, and R160 resulted from a decrease in the maximal reaction velocity V(max) because the apparent Michaelis-Menten constant K(m) values were similar for the mutant and wild-type apoA-I proteins. These data suggest that …

The markedly decreased activities of mutants R149, R153, and R160 resulted from a decrease in the maximal reaction velocity V(max) because t …

9

Effect of mutations of N- and C-terminal charged residues on the activity of LCAT.

Peelman F, Vanloo B, Verschelde JL, Labeur C, Caster H, Taveirne J, Verhee A, Duverger N, Vandekerckhove J, Tavernier J, Rosseneu M. Peelman F, et al. Among authors: rosseneu m. J Lipid Res. 2001 Apr;42(4):471-9. J Lipid Res. 2001. PMID: 11290818 Free article.

10

Displacement of apo A-I from HDL by apo A-II or its C-terminal helix promotes the formation of pre-beta1 migrating particles and decreases LCAT activation.

Labeur C, Lambert G, Van Cauteren T, Duverger N, Vanloo B, Chambaz J, Vandekerckhove J, Castro G, Rosseneu M. Labeur C, et al. Among authors: rosseneu m. Atherosclerosis. 1998 Aug;139(2):351-62. doi: 10.1016/s0021-9150(98)00096-3. Atherosclerosis. 1998. PMID: 9712342

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

202 results

Search Page

Filters